Clinical Practice Guideline

Otolaryngology - Head and Neck Surgery - Tập 146 Số S3 - 2012
Robert J. Stachler1, Sujana S. Chandrasekhar2, Sanford M. Archer3, Richard M. Rosenfeld4, Seth Schwartz5, David M. Barrs6, Steven R. Brown7, Terry D. Fife8, Peg Ford9, Théodore G. Ganiats10, Deena B. Hollingsworth11, Christopher Lewandowski12, Joseph J. Montano13, Heidi Stöckl14, Debara L. Tucci15, Michael Valente16, Barbara Warren17,18, Kathleen Yaremchuk1, Peter J. Robertson19
1Department of Otolaryngology, Henry Ford Hospital, Detroit, Michigan, USA
2New York Otology, New York, New York, USA.
3Division of Otolaryngology–Head & Neck Surgery University of Kentucky Chandler Medical Center Lexington Kentucky USA
4Department of Otolaryngology, SUNY Downstate Medical Center and Long Island College Hospital, Brooklyn, New York, USA
5Department of Otolaryngology Virginia Mason Hospital and Medical Center Seattle Washington USA
6Department of Otolaryngology Mayo Clinic Arizona Phoenix Arizona USA
7Department of Family and Community Medicine University of Arizona School of Medicine Phoenix Arizona USA
8Department of Neurology University of Arizona Phoenix Arizona USA
9Coronado, California, USA
10Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, California. USA
11ENT Specialists of Northern Virginia Falls Church Virginia USA
12Department of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan, USA
13Weill Cornell Medical College, New York, New York, USA
14Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA
15Division of Otolaryngology, Head and Neck Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
16Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri, USA
17City University of New York
18Center for LGBT Social Science & Public Policy Hunter College City University of New York New York New York USA
19American Academy of Otolaryngology–Head and Neck Surgery Foundation Alexandria Virginia USA

Tóm tắt

Objective

Sudden hearing loss (SHL) is a frightening symptom that often prompts an urgent or emergent visit to a physician. This guideline provides evidence‐based recommendations for the diagnosis, management, and follow‐up of patients who present with SHL. The guideline primarily focuses on sudden sensorineural hearing loss (SSNHL) in adult patients (aged 18 and older). Prompt recognition and management of SSNHL may improve hearing recovery and patient quality of life (QOL). Sudden sensorineural hearing loss affects 5 to 20 per 100,000 population, with about 4000 new cases per year in the United States. This guideline is intended for all clinicians who diagnose or manage adult patients who present with SHL.

Purpose

The purpose of this guideline is to provide clinicians with evidence‐based recommendations in evaluating patients with SHL, with particular emphasis on managing SSNHL. The panel recognized that patients enter the health care system with SHL as a nonspecific, primary complaint. Therefore, the initial recommendations of the guideline deal with efficiently distinguishing SSNHL from other causes of SHL at the time of presentation. By focusing on opportunities for quality improvement, the guideline should improve diagnostic accuracy, facilitate prompt intervention, decrease variations in management, reduce unnecessary tests and imaging procedures, and improve hearing and rehabilitative outcomes for affected patients.

Results

The panel madestrong recommendationsthat clinicians should (1) distinguish sensorineural hearing loss from conductive hearing loss in a patient presenting with SHL; (2) educate patients with idiopathic sudden sensorineural hearing loss (ISSNHL) about the natural history of the condition, the benefits and risks of medical interventions, and the limitations of existing evidence regarding efficacy; and (3) counsel patients with incomplete recovery of hearing about the possible benefits of amplification and hearing‐assistive technology and other supportive measures. The panel maderecommendationsthat clinicians should (1) assess patients with presumptive SSNHL for bilateral SHL, recurrent episodes of SHL, or focal neurologic findings; (2) diagnose presumptive ISSNHL if audiometry confirms a 30‐dB hearing loss at 3 consecutive frequenciesandan underlying condition cannot be identified by history and physical examination; (3) evaluate patients with ISSNHL for retrocochlear pathology by obtaining magnetic resonance imaging, auditory brainstem response, or audiometric follow‐up; (4) offer intratympanic steroid perfusion when patients have incomplete recovery from ISSNHL after failure of initial management; and (5) obtain follow‐up audiometric evaluation within 6 months of diagnosis for patients with ISSNHL. The panel offered asoptionsthat clinicians may offer (1) corticosteroids as initial therapy to patients with ISSNHL and (2) hyperbaric oxygen therapy within 3 months of diagnosis of ISSNHL. The panel made arecommendation againstclinicians routinely prescribing antivirals, thrombolytics, vasodilators, vasoactive substances, or antioxidants to patients with ISSNHL. The panel madestrong recommendations againstclinicians (1) ordering computerized tomography of the head/brain in the initial evaluation of a patient with presumptive SSNHL and (2) obtaining routine laboratory tests in patients with ISSNHL.

Từ khóa


Tài liệu tham khảo

10.1002/lary.5540870515

10.1177/000348947708600406

National Institute of Deafness and Communication Disorders.Sudden deafness.2000.http://www.nidcd.nih.gov/health/hearing/sudden.htm. Accessed May 18 2011.

10.1016/S0194-59989570140-0

10.1056/NEJMcp0802129

10.1001/archotol.133.6.582

10.1001/archotol.133.6.573

Fetterman BL, 1996, Prognosis and treatment of sudden sensorineural hearing loss, Am J Otol, 17, 529

10.1097/01.mlg.0000245058.11866.15

10.1016/S1808-8694(15)31268-4

10.1097/01.mao.0000185065.04834.95

Nadol J, Controversy in Otolaryngology, 22

10.1001/jama.2011.679

Byl FM, 1984, Sudden hearing loss: eight years’ experience and suggested prognostic table, Laryngoscope, 94, 647, 10.1288/00005537-198405000-00014

10.1055/s-0028-1128133

Wei BP, 2006, Steroids for idiopathic sudden sensorineural hearing loss, Cochrane Database Syst Rev, 1, CD003998

10.1288/00005537-197603000-00008

Chiossoine‐Kerdel JA, 2000, An investigation of the audiologic handicap associated with unilateral sudden sensorineural hearing loss, Am J Otol, 21, 645

Wie OB, 2010, Unilateral deafness in adults: effects on communication and social interaction, Ann Otol Rhinol Laryngol, 119, 772

10.1044/1059-0889(2010/07-0043)

10.3109/14992027.2010.533705

10.1097/MAO.0b013e31817e5d03

Rosenfeld RM, 2009, Clinical practice guideline development manual: a quality‐driven approach for translating evidence into action, Otolaryngol Head Neck Surg, 140, S1

ShiffmanRN ShekelleP OverhageJM SlutskyJ GrimshawJ DeshpandeAM.Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization.Ann Intern Med.2003;139(6):493‐498.

10.1186/1472-6947-5-23

10.1542/peds.2004-1260

OCEBM Levels of Evidence Working Group. The Oxford2011Levels of Evidence.Oxford Centre for Evidence‐Based Medicine.http://www.cebm.net/index.aspx?o=5653

Eddy DM, 1992, A Manual for Assessing Health Practices and Designing Practice Policies: The Explicit Approach

10.1001/jama.287.5.612

10.1503/cmaj.061181

10.1016/j.otohns.2008.06.026

10.1288/00005537-197912000-00009

10.1093/milmed/153.9.456

10.1001/jama.295.4.416

Miltenburg DM, 1994, The validity of tuning fork tests in diagnosing hearing loss, J Otolaryngol, 23, 254

10.1017/S0022215100107923

10.1002/lary.20873

Haberkamp TJ, 1999, Management of idiopathic sudden sensorineural hearing loss, Am J Otol, 20, 587

10.1097/MOO.0b013e32833d3164

10.1097/00002281-199901000-00008

McCabe BF, 1991, Autoimmune inner ear disease: results of therapy, Adv Otorhinolaryngol, 46, 78

10.1161/01.STR.0000098902.69855.A9

10.1161/01.STR.0000249057.44420.4b

10.1161/STR.0b013e3181f7d043

10.1001/archneur.1993.00540020032014

10.1212/WNL.42.12.2274

10.1161/STROKEAHA.109.564682

10.1136/jnnp.74.12.1644

10.1016/S1052-3057(10)80139-9

10.1001/archneur.58.8.1287

10.1016/S0022-510X(01)00663-3

10.1212/WNL.44.3_Part_1.515

10.1212/WNL.38.9.1490

10.1016/0093-934X(80)90053-X

10.1093/brain/114.6.2385

10.1080/000164800750000207

10.1016/j.jns.2004.10.016

10.1161/STROKEAHA.108.519090

10.1001/archneur.60.1.113

10.1097/00129492-200405000-00008

10.1016/j.otc.2007.10.007

American College of Radiology (ACR).Appropriateness criteria—rating round information.http://www.acr.org/secondarymainmenucategories/quality_safety/app_criteria.aspx

American College of Radiology (ACR).Expert Panel on Neurologic Imaging:Turski PA Wippold FJ II Cornelius RS et al. ACR appropriateness criteria vertigo and hearing loss.1996(last review date: 2008).http://www.acr.org/SecondaryMainMenuCategories/quality_safety/app_criteria/pdf/ExpertPanelonNeurologicImaging/VertigoandHearingLossDoc14.aspx

American College of Radiology (ACR).Appropriateness criteria radiation dose assessment introduction.http://www.acr.org/SecondaryMainMenuCategories/quality_safety/app_criteria/RRLInformation.aspx

10.1288/00005537-198407000-00005

Meijenhorst GC, 1984, High‐resolution CT and air CT cisternography in the diagnosis of acoustic neuromas, Diagn Imaging Clin Med, 53, 120

10.1002/hed.2890050607

10.1227/00006123-199108000-00004

Kamei T, 1989, Comparison between air CT and MRI in the detection of small acoustic neurinomas, Radiat Med, 7, 16

Wilms G, 1989, Magnetic resonance imaging in acoustic neurinoma: comparison with CT, J Belge Radiol, 72, 151

10.3109/00016489109131472

10.1177/000348948609500104

10.1288/00005537-198704000-00012

10.1007/BF00548194

10.1016/S0887-2171(01)90009-5

10.1001/archotol.1980.00790360050013

10.1201/b15118-290

American Speech‐Language‐Hearing Association.Preferred practice patterns for the profession of audiology.2006.www.asha.org/policy

American National Standards Institute (ANSI), 2003, Maximum Permissible Ambient Noise Levels for Audiometric Test Rooms (ANSI S3.1‐R2003)

American National Standards Institute (ANSI), 2004, Specifications for Audiometers (ANSI S3.6‐R2004)

American Speech‐Language‐Hearing Association.Guidelines for manual pure‐tone threshold audiometry.2005.www.asha.org/policy

American National Standards Institute (ANSI), 1978, Methods for Manual Pure‐Tone Threshold Audiometry (ANSI S3.21‐1978, R‐1986)

American Speech‐Language‐Hearing Association.Guidelines for audiometric symbols.1990.www.asha.org/policy

10.1097/00129492-200601000-00020

10.1044/jshr.2103.507

10.1080/000164800750061688

10.1080/000164802753648105

10.1177/000348940411300605

10.1177/000348940611500307

10.1080/00016480152602276

10.1016/j.otohns.2005.10.064

10.1080/00016480410016216

10.1177/000348941011900203

10.1001/archotol.124.6.633

10.1080/00016480510030246

10.1016/S1808-8694(15)31193-9

10.1177/000348941011900908

10.3109/00016480903161541

10.3310/hta13180

10.1111/j.1365-2273.2004.00822.x

10.1097/MLG.0b013e3181453a07

10.1016/j.jocn.2010.01.018

10.3171/jns.2005.102.1.0010

10.3171/2008.12.JNS08611

10.1007/s11060-009-9842-3

10.3109/02688690903272634

10.1097/00005537-200503000-00011

10.1097/00129492-200207000-00024

10.1177/014107688908200606

10.1016/S0194-5998(98)70080-4

Fitzgerald DC, 1998, Sudden hearing loss: frequency of abnormal findings on contrast‐enhanced MR studies, AJNR Am J Neuroradiol, 19, 1433

10.1097/00129492-200111000-00016

10.2310/7070.2006.0066

10.1186/1472-6815-10-6

10.2214/AJR.10.4885

10.1016/j.juro.2008.05.005

Montaguti M, 2007, Comparative evaluation of ABR abnormalities in patients with and without neurinoma of VIII cranial nerve, Acta Otorhinolaryngol Ital, 27, 68

Chandrasekhar SS, 1995, Utility of auditory brainstem response audiometry in diagnosis of acoustic neuromas, Am J Otol, 16, 63

10.1097/00003446-200006000-00010

10.1001/archotol.127.1.19

10.1177/019459988609400506

National Institute for Occupational Safety and Health.Hearing loss prevention.http://www.cdc.gov/niosh/programs/hlp/risks.html. Accessed July 25 2011.

10.1001/jama.2010.1208

Elwyn G, 2009, Shared Decision‐Making in Health Care: Achieving Evidence‐Based Patient Choice, 10.1093/oso/9780199546275.001.0001

10.1111/j.1365-2753.2004.00502.x

O’Connor AM, 2009, Decision aids for people facing health treatment or screening decisions, Cochrane Database Syst Rev, CD001431

10.2165/00003495-198836060-00005

10.1097/AUD.0b013e3181c351f2

10.1002/lary.21011

Moskowitz D, 1984, Steroid use in idiopathic sudden sensorineural hearing loss, Laryngoscope, 94, 664, 10.1288/00005537-198405000-00016

Stokroos RJ, 1996, Therapy of idiopathic sudden sensorineural hearing loss: a review of the literature, Acta Otorhinolaryngol Belg, 50, 77

10.1097/00129492-200309000-00006

10.1136/emj.2005.029066

10.1016/j.otohns.2005.05.015

10.1080/00016480500504234

10.1007/BF00464440

10.1097/00005537-199907001-00001

10.1097/01.mao.0000185052.07513.5a

10.1177/000348940711600405

10.1097/MAO.0b013e31816fdcb4

10.3109/00365527809182199

UpToDate Inc. Methylprednisolone: drug information.http://www.uptodate.com/contents/methylprednisolone‐drug‐information. Accessed May 15 2011.

SaagKG FurstDE.Major side effects of systemic glucocorticords.http://www.uptodate.com/contents/major‐side‐effects‐of‐systemic‐glucocorticoids?source=search_result&selectedTitle=1~150. Accessed May 18 2011.

Drugs.com. MethylPREDNISolone Dose Pack.http://www.drugs.com/mtm/methylprednisolone‐dose‐pack.html. Accessed May 18 2011.

10.2165/00003495-197816030-00006

Holland EG, 1991, Glucocorticoids in clinical practice, J Fam Pract, 32, 512

10.1177/0194599810390470

10.1097/MAO.0b013e3181a52773

10.1097/BOR.0b013e3282f51031

10.1097/00129492-200101000-00005

10.1016/j.otohns.2005.01.024

10.1097/MAO.0b013e318168da7a

10.1097/MLG.0b013e3181585428

10.3109/00016481003793766

10.1097/MAO.0b013e3181f7aba3

10.1097/01.mao.0000224092.79635.ee

10.1016/j.otohns.2009.06.084

10.1067/mhn.2000.102578

10.1159/000313506

10.1097/MOO.0b013e32830ce796

10.1159/000241894

10.1097/00129492-200411000-00031

10.1007/s00405-006-0065-3

10.1097/01.moo.0000244190.51560.6b

10.1093/qjmed/hch074

Bennett MH, 2007, Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus, Cochrane Database Syst Rev, CD004739

CavallazziG PignataroL CapaccioP.Italian experience in hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.Paper presented at: International Joint Meeting on Hyperbaric and Underwater Medicine;September 5‐8 1996;Milan Italy.

10.1177/014556130108000911

Hoffman G, 1995, Proceedings of the Eleventh International Congress on Hyperbaric Medicine

Hoffmann G, 1995, Proceedings of the Eleventh International Congress on Hyperbaric Medicine

10.1055/s-2007-1008158

Schwab B, 1998, EUBS Diving and Hyperbaric Medicine, Collected Manuscripts of XXIV Annual Scientific Meeting of the European Underwater and Baromedical Society

10.1007/s00405-003-0688-6

10.1017/S0022215109004277

Plafki C, 2000, Complications and side effects of hyperbaric oxygen therapy, Aviat Space Environ Med, 71, 119

10.1288/00005537-199201000-00009

10.1007/s00405-010-1336-6

10.1159/000111048

10.1097/00129492-200205000-00012

10.1016/S0194-59980300004-4

10.1177/000348940311201113

10.1080/00016489850154603

Fisch U, 1984, Sudden hearing loss: circulatory, Am J Otol, 5, 488

10.3109/00016487309121486

10.1288/00005537-195906000-00001

Mattox DE, 1989, Idiopathic sudden sensorineural hearing loss, Am J Otol, 10, 242

10.1080/000164801316878854

10.1007/BF00470614

Agarwal L, 2009, Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss, Cochrane Database Syst Rev, CD003422

10.1080/0036554021000028082

10.1111/j.1365-2273.1989.tb00336.x

10.1016/S0363-0188(76)80006-0

10.1016/S1043-1810(01)80009-9

10.1080/00016480701477602

10.1097/00005537-200407000-00010

10.1016/j.otohns.2005.03.081

10.1002/lary.20074

10.1080/00016480601126952

10.1080/00016480510037898

Lee HS, 2008, Results of intratympanic dexamethasone injection as salvage treatment in idiopathic sudden hearing loss, J Otolaryngol Head Neck Surg, 37, 263

10.1097/MAO.0b013e31802fba7a

10.1097/MAO.0b013e3181c34f18

10.1016/j.otohns.2006.10.021

10.1044/leader.FTR2.13152008.14

10.1097/00003446-199012000-00004

10.1001/archotol.1996.01890140029007

10.1097/00003446-198205000-00006

10.3766/jaaa.18.2.7

ValenteM AbramsH BensonB et al.Guidelines for the audiologic management of adult hearing impairment.2008.http://www.audiology.org/resources/documentlibrary/Documents/haguidelines.pdf

10.3766/jaaa.16.7.8

10.1258/0022215011909323

10.1007/s004059900206

10.1258/ijsa.2007.007221

10.1159/000393099

Federspil P, 1981, Drug‐induced sudden hearing loss and vestibular disturbances, Adv Otorhinolaryngol, 27, 144

10.1097/00005537-199709000-00003

10.1017/S0022215100111028

Chandrasekhar SS, 1992, Histopathologic and ultrastructural changes in the temporal bones of HIV‐infected human adults, Am J Otol, 13, 207

Mahmoudian T, 2009, Blood lead levels in children with neurological disorders: a single centre preliminary study, Zhongguo Dang Dai Er Ke Za Zhi, 11, 873

10.1093/bmb/63.1.73

10.1007/s00439-002-0762-y

10.1093/brain/123.1.82

10.1097/00005537-200308000-00018

10.1097/00005537-199606000-00021

10.1097/MLG.0b013e3180303ed0

10.1161/01.STR.24.1.132

10.1212/WNL.52.1.40

10.1016/j.jns.2005.01.001

10.1177/019459989210600134

10.1177/019459988609400103

10.4295/audiology.49.284

10.1177/014556131109000111

10.1002/jca.20081

10.1046/j.1365-2273.2002.00620.x

10.4103/0970-9185.74937

10.1017/S0022215109992052

10.1067/mhn.2002.121915

10.3950/jibiinkoka.103.506

Desloovere C, 2006, Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness, B‐ENT, 2, 69

10.1097/00129492-200411000-00010

Lamm K, 1998, Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise‐induced hearing loss and tinnitus: a literature survey, Adv Otorhinolaryngol, 54, 86

Ohno K, 2010, Secondary hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss in the subacute and chronic phases, J Med Dent Sci, 57, 127

10.1016/j.anl.2007.06.003

10.1007/s00405-007-0272-6

10.1097/01.mlg.0000205183.29986.f6

10.1159/000093093

10.1016/j.otohns.2006.03.035

10.1016/j.otohns.2007.01.022

10.1007/s00405-004-0772-6

10.1177/014556139607500806

10.1097/00129492-200107000-00011